Given the tumor's features (diameter of 0.6 cm, grade 1, ER-positive, PR-positive, HER2-negative, and Ki67 index of 14%, indicating a low risk of recurrence), only hormonal therapy is being administered. This evidence concerns the gene ESR1 and neoplasm.